Instil Bio TIL
NASDAQ TIL
$5.78 -0.16 (-2.61%)
As of: Oct 21, 2026 · 3:59 PM EDT

Instil Bio (TIL) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Instil Bio's Liabilities and Shareholders Equity came in at $197.71 million for Q2 2026, down 14.4% from $230.99 million a year earlier and down 1.4% from the prior quarter.

Analysis

Instil Bio (TIL) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Instil Bio's Liabilities and Shareholders Equity was $203.52 million, down 22.8% from FY2024.

  • Liabilities and Shareholders Equity has declined in each of the last four years, with a five-year compound annual growth rate of -8.6% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $263.57 million in FY2024 (-19.1%), $325.63 million in FY2023 (-32.5%), $482.13 million in FY2022 (-21.0%) and $609.98 million in FY2021 (+91.2%).
  • The Q2 2026 figure represents the lowest quarterly Liabilities and Shareholders Equity in data going back to Q4 2020.
  • Year-over-year, Liabilities and Shareholders Equity has declined for 18 consecutive quarters, with an average decline of 19.8% over the last eight quarters.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q4 2021 (growth of 91.2%), and the weakest in Q3 2023 (a decline of 36.1%).
  • Business Quant data shows TIL's Liabilities and Shareholders Equity at $200.43 million (Q1 2026), $203.52 million (Q4 2025) and $211.77 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 201.06 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 135.12 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 115.83 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 49.36 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 201.13 Bn
10 Instil Bio 38.86 Mn 15.86 Mn - 197.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 197.71 Mn
Mar 31, 2026 200.43 Mn
Dec 31, 2025 203.52 Mn
Sep 30, 2025 211.77 Mn
Jun 30, 2025 230.99 Mn
Mar 31, 2025 237.45 Mn
Dec 31, 2024 263.57 Mn
Sep 30, 2024 272.56 Mn
Jun 30, 2024 294.32 Mn
Mar 31, 2024 306.30 Mn
Dec 31, 2023 325.63 Mn
Sep 30, 2023 340.27 Mn
Jun 30, 2023 408.31 Mn
Mar 31, 2023 427.17 Mn
Dec 31, 2022 482.13 Mn
Sep 30, 2022 532.74 Mn
Jun 30, 2022 568.54 Mn
Mar 31, 2022 564.94 Mn
Dec 31, 2021 609.98 Mn
Sep 30, 2021 647.40 Mn
API Access

Instil Bio Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TIL&period=max&api_key=YOUR_API_KEY